• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Early onset Lewy Body Dementia is more clinically distinct from Alzheimer Dementia than late onset Lewy Body Dementia

byGursharan SohiandMichael Pratte
May 25, 2022
in Chronic Disease, Neurology, Psychiatry
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Select features distinguish early-onset Lewy Body Dementia from early-onset Alzheimer dementia, including: hallucinations, slowness, apathy and motor deterioration.

2. Late-onset Lewy Body Dementia is more likely to have amnestic features and closely resemble Alzheimer’s disease compared to early-onset Lewy Body Dementia.

Evidence Rating Level: 3 (Average)

Study Rundown: Lewy body dementia (LBD) is one of the most common neurodegenerative diseases after Alzheimer disease (AD). It is characterized by parkinsonian traits, hallucinations, postural instability and altered states of behavior. The present study sought to describe differentiating features between early-onset LBD and (1) AD as well as (2) late-onset LBD. A total of 542 patients were included; 363 had early-onset AD, 147 had late-onset LBD and 32 had early-onset LBD.  Patients with early-onset LBD tended to be older at the time of diagnosis, live fewer years after diagnosis and perform better on the baseline Mini Mental Status Exam (MMSE) than those with early-onset AD. Other differentiating features included: hallucinations and delusions, parkinsonian disordered movements and behavioral symptoms in LBD patients. The primary differences between early- and late-onset LBD included worse scores on neuropsychological testing, poorer memory and reduced medication use in late-onset patients. On pathologic examination, late-onset LBD patients were more likely to have neuritic plaque distributed diffusely in the brain as seen in AD. This retrospective study identified a number of clinical characteristics which help to distinguish AD from LBD, particularly in early stages of disease. It also noted key pathologic and clinical differences between early and late-onset LBD. This work adds to the growing understanding of neurodegenerative diseases and may facilitate earlier, and more accurate diagnosis. A key strength of this work is the large sample size, and the correlation of clinical data with pathologic diagnoses. This work is limited by its retrospective nature and some differences in the size and composition of the subgroups compared. Future research should work to fill these gaps and further validate these findings in a real-world clinical setting.

Click here to read this article in JAMA Neurology

Relevant reading: Distinguishing Lewy body dementia from Alzheimer’s disease

In Depth [case-control study]: A retrospective, case-control study was performed. Study data was derived from the health records of deceased patients who had pathologically-confirmed LBD or AD. Patients were further classified as having early onset disease if they were diagnosed prior to the age of 65 and late-onset disease if they were diagnosed thereafter. Demographic and clinical data were derived from the National Alzheimer Coordinating Center database. 79.9% of the clinically-diagnosed AD patients were also pathologically diagnosed, while only 50% of LDB diagnoses were pathologically confirmed. The strongest differentiating traits between early-onset LBD and AD (p<0.001) were the following: psychosis (46.9% LBD versus 11.6% AD), sleep behavioral disorders (15.6% vs. 6.6%), gait disorder (62.5% vs 22.0%), tremors (53.1% vs. 11.0%), motor slowing (71.9% vs. 26.2%) and depressed mood as per the Geriatric Depression Scale (3.70% vs. 2.66%). The five features thought to best differentiate the two syndromes, listed here with their odds ratios include: initial motor changes (32.01, 95% confidence interval 6.99-146.56), slowness (3.75, 1.43-9.81), apathy (4.67, 1.20-18.20), agitation (0.11, 0.02-0.59) and visual hallucinations (7.95, 2.93-21.57).

RELATED REPORTS

The 2 Minute Medicine Podcast Episode 6

#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo

Lecanemab may slow cognitive decline in early Alzheimer’s disease

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: alzheimerAlzheimer’s diseasedementia with Lewy bodies
Previous Post

Pelvic lymph node radiotherapy and androgen deprivation therapy augment progression-free status following prostatectomy

Next Post

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

RelatedReports

2MM Podcast

The 2 Minute Medicine Podcast Episode 6

January 13, 2023
#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo
StudyGraphics

#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo

January 12, 2023
Free alternatives comparable to Mini-Mental State Examination
Chronic Disease

Lecanemab may slow cognitive decline in early Alzheimer’s disease

January 10, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

January 11, 2023
Next Post
FDA-approved weight loss medications associated with weight loss at one year

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Wellness Check: Sleep

#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly

#VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cystatin C-based equation without race or sex improves accuracy of GFR estimation
  • #VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension
  • High-dose exercise therapy is not superior to low-dose exercise therapy for knee osteoarthritis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options